ACTH-Secreting Neuroendocrine Carcinoma of the Cecum: Case Report and Review of the Literature

Adrenocorticotropic hormone-secreting neuroendocrine tumors of the colon are rare. We describe a case of BRAF V600E and TP53 mutations detected with next-generation sequencing (NGS) and performed a comprehensive literature review. Eighteen cases were found with an unadjusted mortality rate of 77.7% and median survival from presentation of 63 days. NGS may be important to identify these rare tumors. Approximately 30% of neuroendocrine tumors (NETs) present with secretory syndromes or develop one during the course of the disease. Cushing syndrome caused by a gastrointestinal tract NET is rare, with limited published information. We describe a patient with florid Cushing syndrome due to ectopic adrenocorticotropic hormone (ACTH) from a NET of colonic origin. A literature review was conducted to describe the spectrum of this clinical and pathologic entity as reported in the scientific literature. Next-generation sequencing and microsatellite instability testing was carried out on the tumor from our case. A preliminary PubMed search was conducted using the following terms under the publication type “Case Reports”: “Cushing” AND “colon,” “neuroendocrine” AND “colon” and “neuroendocrine AND Cushing AND “colon.” A manual search was performed to review all references for inclusion and relevant clinical, biochemical and pathologic data was abstracted. Mutations in BRAF V600E and TP53 were detected in our case. We retrieved 18 previously reported cases of Cushing syndrome associated with a NET of colonic origin, none of which had next-generation sequencing performed. Median age at diagnosis was 54.5 years (range, 24-74 years), with equal gender distribution. ACTH was detected by immunohistochemistry in the primary tumor and/or metastatic lesion in 61.5%. Review of the reports suggested that ectopic ACTH secretion from a colonic tumor might be more common in mixed glandular and NETs, including mixed adenocarcinoma–neuroendocrine carcinoma. Among studies reporting outcomes, the unadjusted mortality rate was 77.7%, with median overall survival from presentation of 63 days (range, 17-380 days). Cushing syndrome associated with ectopic ACTH from tumors of colonic origin is a rare phenomenon with poor outcomes and can be associated with pure NETs, adenocarcinomas, and mixed-phenotype tumors, including mixed adenocarcinoma–neuroendocrine carcinoma.